Sophia Su is an experienced healthcare and life sciences investor, currently serving as Investment Director at Junson Capital, a multi-billion-dollar family office specializing in global investments across multiple asset classes. She focuses on healthcare private equity and venture investments with a track record of leading and participating in deals across various stages, from early-stage innovations to mid-to-late-stage ventures. Prior to joining Junson Capital, Sophia was responsible for healthcare private equity investments at Cathay Capital, where she concentrated on biopharmaceuticals, medical devices, and healthcare technologies.

She has played a key role in investing in breakthrough innovations originating from MIT, Harvard, UCSD, and other top academic institutions. Additionally, she holds Board Director and Observer positions in several portfolio companies, providing strategic guidance on growth and commercialization.

Sophia holds a Bachelor of Medicine, Bachelor of Surgery (MBBS) from Shanghai Jiao Tong University and a Master of Science in Engineering from MIT. She is actively engaged in the global healthcare investment community and continues to support the advancement of innovative life sciences technologies.